You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 17, May 7, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Intervention
 •Pacemakers/ Defibrillators
 •Alert me on articles by topic

Is There an Effective Treatment for Neurally Mediated Syncope?

Wishwa N. Kapoor, MD, MPH

JAMA. 2003;289:2272-2275.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

During the past 20 years, a great deal has been learned about the evaluation, management, and prognosis of syncope. Studies from the 1980s showed that for approximately half of patients with syncope, the cause could not be established using diagnostic tests widely available at the time.1 Studies of risk stratification showed that the most important predictor of a poor outcome was underlying structural heart disease, including abnormalities detected on electrocardiogram.2-3 These findings prompted investigators to devise new diagnostic tests and to propose alternative strategies for managing syncope.

In the subset of patients with syncope and structural heart disease, the focus shifted to extensive evaluation of cardiovascular disease and to the use of electrophysiological studies to test for arrhythmias. In the subset of patients who have syncope, but in whom structural heart disease or other cardiac etiology could not be diagnosed and did not seem clinically . . . [Full Text of this Article]

Author Affiliation: Department of Medicine, University of Pittsburgh, Pittsburgh, Pa.


RELATED ARTICLE

Pacemaker Therapy for Prevention of Syncope in Patients With Recurrent Severe Vasovagal Syncope: Second Vasovagal Pacemaker Study (VPS II): A Randomized Trial
Stuart J. Connolly, Robert Sheldon, Kevin E. Thorpe, Robin S. Roberts, Kenneth A. Ellenbogen, Bruce L. Wilkoff, Carlos Morillo, and Michael Gent
JAMA. 2003;289(17):2224-2229.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Norepinephrine Transporter Inhibition Prevents Tilt-Induced Pre-Syncope
Schroeder et al.
J Am Coll Cardiol 2006;48:516-522.
ABSTRACT | FULL TEXT  

Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope
Brignole et al.
Eur Heart J 2006;27:1085-1092.
ABSTRACT | FULL TEXT  

Simple Self-Help Maneuvers Are Effective in Aborting Vasovagal Syncope * Response
Cheng et al.
Circulation 2004;109:e217-e217.
FULL TEXT  

Autonomic Syncope in Pediatrics: A Practice-Oriented Approach to Classification, Pathophysiology, Diagnosis, and Management
Sapin
CLIN PEDIATR 2004;43:17-23.
ABSTRACT  

Neurally Mediated Syncope -- Are Pacemakers Effective?
JWatch General 2003;2003:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.